Clinical TrialID 6911

The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia

NCT02274051

Familial Dysautonomia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6911
Evidence Id
6911
Core Evidence Id
6911
Source Clinical Trial Id
6903
Herb2 Clinical Trial Id
HBCT006903
Nct Id
NCT02274051
Title
The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Familial Dysautonomia
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: Kinetin
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
15
Outcome Measure
Change in Safety blood labs, safety blood labs (CBC, metabolic panel), At baseline and after each 6 months period and at 36 months|Change in vital signs, Sitting and standing blood pressure measurements and heart rate, At baseline and after each 6 months period and at 36 months|Change in ECG, 12 lead ECG measures, At baseline and after each 6 months period and at 36 months|Number of participants with adverse events, Number of adverse events, At baseline and after each 6 months period and at 36 months
Sponsor Collaborator
NYU Langone Health
Funded By
OTHER
Location
NYU Langone Medical Center, New York, New York, 10016, United States
Other Id
09-0762
Start Date
2009-11
Primary Completion Date
2019-05-04
Completion Date
2019-05-04
First Posted
2014-10-24
Results First Posted
Last Update Posted
2019-06-18
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02274051
Title Cn
Title En
The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
Bilingual Status
semi_complete